Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.342NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.90NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.169NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.528NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.175NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.483NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.181NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.113NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.594NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.328NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.145NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.547NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.247NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.205NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.434NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.181NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.6.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.112NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.123NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.143NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46.6.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.360NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.347NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.195NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.321NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.379NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.78NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.231NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.190NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.120NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.249NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.505NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.406NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used